We enable life science companies to become investable through realistic assumptions, robust business cases and clear negotiation positions on equal footing. From rigorous valuation to a successful financing round.
Why VC readiness is more than a pitch
Many financing round do not fail because of weak science, but because of a gap between entrepreneurial vision and investor reality. Typical challenges include:
- Unrealistic assumptions in business cases
- Narratives that do not withstand due diligence
- Insufficient preparation for critical investor questions
- Asymmetric negotiation situations
Excellere closes this gap, not as a traditional VC, but as an independent sparring partner on equal footing.
We evaluate like an investor and act like a partner
Excellere acts as a strong partner at your side and prepares you thoroughly for upcoming financing rounds. Not by overstating opportunities, but because we:
- Evaluate companies based on realistic and defensible assumptions
- Address weaknesses openly without artificially eroding value
- Enable founding teams and management to negotiate on equal footing
Our objective is not to push valuations or polish narratives, but to achieve the optimal outcome of a financing round based on a realistic evaluation.
Who this service is particularly relevant for
Startups and scaleups that
- Are preparing for VC discussions or financing rounds
- Want to build a business case that is ambitious yet realistic
- Require a clear investment story that withstands due diligence
- Seek structured sparring with relevant domain expertise during investor discussions
Objective: Strong negotiation position, credible narrative and higher probability of closing.
Established companies and investors that
- Intend to evaluate external assets or acquisition targets
- Require sound decision bases beyond purely financial models
- Need to realistically assess commercial, market access and development risks
Objective: Robust valuations and transparent decision making.
Our services in evaluation and VC readiness
Focus
Realistic, scenario based business cases as the foundation of every investment decision.
Typical questions
- How realistic are market potential, pricing assumptions and uptake?
- Which assumptions drive value and which are critical?
- How robust is the case across worst, base and best case scenarios?
Focus
Independent evaluation of assets and companies from a commercial and market access perspective.
Typical questions
- Is the value potential realistically achievable?
- Where are the key commercial or structural risks?
- How robust ist the management narrative?
Focus
Translation of complex scientific and commercial content into a clear investment story.
Typical questions
- Which narratives remain consistent across multiple financing rounds?
- How can risks be addressed without undermining trust?
- How should management teams prepare for critical investor questions?
Focus
Transparent and comprehensible models as a common language with investors and venture capital.
Typical questions
- How consistent are assumptions across models, slides and discussions?
- Which sensitivities must be actively managed?
- Which KPIs are investor relevant?
How we work in practice
- Joint development of realistic assumptions
- Structured preparation for investor discussions
- Sparring during ongoing investor negotiations
- Support in adapting business cases, pitches and underlying narratives
- Clear focus on decision quality and negotiation confidence
Why Excellere
- Senior executive only engagement
- Extensive experience across industry, VC interactions and successful commercializations
- Independent from investor interests
- Focus on financing outcomes, not slide decks
When a financing round or valuation is upcoming
Whether you are preparing a financing round, negotiating with investors or evaluating external assets, let us asses together how Excellere can support you in achieving the best possible outcome.
-10.jpg/picture-200?_=197ceb51780)